• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

循环微RNA与动脉粥样硬化的全身范围相关:miR-27b和miR-146的新发现

Circulating miRNAs Are Associated with the Systemic Extent of Atherosclerosis: Novel Observations for miR-27b and miR-146.

作者信息

Pereira-da-Silva Tiago, Napoleão Patrícia, Costa Marina C, Gabriel André F, Selas Mafalda, Silva Filipa, Enguita Francisco J, Ferreira Rui Cruz, Carmo Miguel Mota

机构信息

Department of Cardiology, Hospital de Santa Marta, Centro Hospitalar Universitário de Lisboa Central, 1169-024 Lisbon, Portugal.

NOVA Medical School, Faculdade de Ciências Médicas, Universidade NOVA de Lisboa, 1169-056 Lisbon, Portugal.

出版信息

Diagnostics (Basel). 2021 Feb 16;11(2):318. doi: 10.3390/diagnostics11020318.

DOI:10.3390/diagnostics11020318
PMID:33669374
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7920287/
Abstract

The mechanisms that regulate the systemic extent of atherosclerosis are not fully understood. We investigated whether the expression of circulating miRNAs is associated with the extent of stable atherosclerosis to a single territory or multiple territories (polyvascular) and with the severity of atherosclerosis in each territory. Ninety-four participants were prospectively recruited and divided into five age- and sex-matched groups: presenting no atherosclerosis, isolated coronary atherosclerosis, coronary and lower extremity atherosclerosis, coronary and carotid atherosclerosis, and atherosclerosis of the coronary, lower extremity, and carotid territories. The expression of six circulating miRNAs with distinct biological roles was assessed. The expression of miR-27b and miR-146 differed across groups ( < 0.05), showing a decrease in the presence of atherosclerosis, particularly in the three territories. miR-27b and miR-146 expression decreased in association with a higher severity of coronary, lower extremity, and carotid atherosclerosis. Polyvascular atherosclerosis involving the three territories was independently associated with a decreased miR-27b and miR-146 expression. Both miRNAs presented an area under the curve of ≥0.75 for predicting polyvascular atherosclerosis involving the three territories. To conclude, miR-27b and miR-146 were associated with the presence of severe polyvascular atherosclerosis and with the atherosclerosis severity in each territory. Both are potential biomarkers of severe systemic atherosclerosis.

摘要

调节动脉粥样硬化全身范围的机制尚未完全明确。我们研究了循环miRNA的表达是否与单一区域或多个区域(多血管)的稳定动脉粥样硬化范围以及每个区域的动脉粥样硬化严重程度相关。前瞻性招募了94名参与者,并将其分为五个年龄和性别匹配的组:无动脉粥样硬化、孤立性冠状动脉粥样硬化、冠状动脉和下肢动脉粥样硬化、冠状动脉和颈动脉粥样硬化,以及冠状动脉、下肢和颈动脉区域的动脉粥样硬化。评估了六种具有不同生物学作用的循环miRNA的表达。miR-27b和miR-146的表达在各组间存在差异(<0.05),在存在动脉粥样硬化时表达降低,尤其是在三个区域。miR-27b和miR-146的表达随着冠状动脉、下肢和颈动脉粥样硬化严重程度的增加而降低。涉及三个区域的多血管动脉粥样硬化与miR-27b和miR-146表达降低独立相关。两种miRNA在预测涉及三个区域的多血管动脉粥样硬化时曲线下面积均≥0.75。总之,miR-27b和miR-146与严重多血管动脉粥样硬化的存在以及每个区域的动脉粥样硬化严重程度相关。两者都是严重全身性动脉粥样硬化的潜在生物标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d586/7920287/1d93f8c8776c/diagnostics-11-00318-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d586/7920287/b77e64ab8531/diagnostics-11-00318-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d586/7920287/1d93f8c8776c/diagnostics-11-00318-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d586/7920287/b77e64ab8531/diagnostics-11-00318-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d586/7920287/1d93f8c8776c/diagnostics-11-00318-g002.jpg

相似文献

1
Circulating miRNAs Are Associated with the Systemic Extent of Atherosclerosis: Novel Observations for miR-27b and miR-146.循环微RNA与动脉粥样硬化的全身范围相关:miR-27b和miR-146的新发现
Diagnostics (Basel). 2021 Feb 16;11(2):318. doi: 10.3390/diagnostics11020318.
2
The Proinflammatory Soluble CD40 Ligand Is Associated with the Systemic Extent of Stable Atherosclerosis.促炎可溶性 CD40 配体与稳定动脉粥样硬化的全身程度相关。
Medicina (Kaunas). 2021 Jan 4;57(1):39. doi: 10.3390/medicina57010039.
3
Cigarette Smoking, miR-27b Downregulation, and Peripheral Artery Disease: Insights into the Mechanisms of Smoking Toxicity.吸烟、miR-27b下调与外周动脉疾病:对吸烟毒性机制的见解
J Clin Med. 2021 Feb 22;10(4):890. doi: 10.3390/jcm10040890.
4
Circulating microRNA profiles in different arterial territories of stable atherosclerotic disease: a systematic review.稳定型动脉粥样硬化疾病不同动脉区域的循环微小RNA谱:一项系统综述
Am J Cardiovasc Dis. 2018 Feb 5;8(1):1-13. eCollection 2018.
5
The role of miRNAs in the diagnosis of stable atherosclerosis of different arterial territories: A critical review.微小RNA在不同动脉区域稳定动脉粥样硬化诊断中的作用:一项批判性综述。
Front Cardiovasc Med. 2022 Nov 25;9:1040971. doi: 10.3389/fcvm.2022.1040971. eCollection 2022.
6
Circulating miR-27b as a Biomarker of the Development and Progression of Carotid Artery Stenosis.循环 miR-27b 作为颈动脉狭窄发展和进展的生物标志物。
Clin Appl Thromb Hemost. 2021 Jan-Dec;27:10760296211057903. doi: 10.1177/10760296211057903.
7
Soluble CD40 ligand expression in stable atherosclerosis: A systematic review and meta-analysis.可溶性 CD40 配体在稳定动脉粥样硬化中的表达:系统评价和荟萃分析。
Atherosclerosis. 2021 Feb;319:86-100. doi: 10.1016/j.atherosclerosis.2020.12.011. Epub 2020 Dec 15.
8
SIV Infection Regulates Compartmentalization of Circulating Blood Plasma miRNAs within Extracellular Vesicles (EVs) and Extracellular Condensates (ECs) and Decreases EV-Associated miRNA-128.SIV 感染调节循环血浆 miRNA 在细胞外囊泡(EVs)和细胞外凝聚物(ECs)中的区室化,并降低 EV 相关 miRNA-128。
Viruses. 2023 Feb 24;15(3):622. doi: 10.3390/v15030622.
9
miR-27b inhibits LDLR and ABCA1 expression but does not influence plasma and hepatic lipid levels in mice.微小RNA-27b抑制低密度脂蛋白受体(LDLR)和三磷酸腺苷结合盒转运体A1(ABCA1)的表达,但不影响小鼠的血浆和肝脏脂质水平。
Atherosclerosis. 2015 Dec;243(2):499-509. doi: 10.1016/j.atherosclerosis.2015.09.033.
10
Association between low levels of serum miR-638 and atherosclerotic plaque vulnerability in patients with high-grade carotid stenosis.血清miR-638水平降低与重度颈动脉狭窄患者动脉粥样硬化斑块易损性之间的关联。
J Neurosurg. 2019 Jul 1;131(1):72-79. doi: 10.3171/2018.2.JNS171899. Epub 2018 Jul 27.

引用本文的文献

1
miRNome profile in blood samples upstream and downstream of the coronary lesion and arterial aortic root before and after angioplasty in subjects with chronic and acute coronary syndrome: A pilot observational study protocol (Plaque study).慢性和急性冠状动脉综合征患者血管成形术前和术后冠状动脉病变上下游及主动脉根部血液样本中的微小RNA谱:一项初步观察性研究方案(斑块研究)
PLoS One. 2025 Jun 13;20(6):e0324467. doi: 10.1371/journal.pone.0324467. eCollection 2025.
2
Evaluation of miR-146a as a potential biomarker for diagnosis of cardiotoxicity induced by chemotherapy in patients with breast cancer.评估miR-146a作为乳腺癌患者化疗所致心脏毒性诊断潜在生物标志物的价值。
J Res Med Sci. 2025 Jan 30;30:4. doi: 10.4103/jrms.jrms_840_22. eCollection 2025.
3

本文引用的文献

1
The Interplay between Oxidative Stress and miRNAs in Obesity-Associated Hepatic and Vascular Complications.氧化应激与微小RNA在肥胖相关肝脏和血管并发症中的相互作用
Antioxidants (Basel). 2020 Jul 10;9(7):607. doi: 10.3390/antiox9070607.
2
Circulatory miR-133b and miR-21 as Novel Biomarkers in Early Prediction and Diagnosis of Coronary Artery Disease.循环 miR-133b 和 miR-21 作为冠状动脉疾病早期预测和诊断的新型生物标志物。
Genes (Basel). 2020 Feb 5;11(2):164. doi: 10.3390/genes11020164.
3
Polyvascular Disease: Reappraisal of the Current Clinical Landscape.
The involvement of circulating miR-146a and miR-27a in patients with atherosclerotic cardiovascular disease after SARS-CoV-2 infection.循环 miR-146a 和 miR-27a 在感染 SARS-CoV-2 后发生动脉粥样硬化性心血管疾病患者中的作用。
Clin Cardiol. 2024 Jun;47(6):e24274. doi: 10.1002/clc.24274.
4
Deregulated miR-146a-3p alleviates disease progression in atherosclerosis through inactivating NF-κB: An experimental study.miR-146a-3p 的失调通过使 NF-κB 失活来缓解动脉粥样硬化的疾病进展:一项实验研究。
Medicine (Baltimore). 2024 May 17;103(20):e38061. doi: 10.1097/MD.0000000000038061.
5
Synergistic Effects of Weight Loss and Catheter Ablation: Can microRNAs Serve as Predictive Biomarkers for the Prevention of Atrial Fibrillation Recurrence?减肥与导管消融联合治疗的协同效应:微小 RNA 能否作为预防心房颤动复发的预测性生物标志物?
Int J Mol Sci. 2024 Apr 25;25(9):4689. doi: 10.3390/ijms25094689.
6
Adipose-derived stem cell exosomes act as delivery vehicles of microRNAs in a dog model of chronic hepatitis.脂肪干细胞外泌体在慢性肝炎犬模型中作为 microRNAs 的递药载体。
Nanotheranostics. 2024 Mar 9;8(3):298-311. doi: 10.7150/ntno.93064. eCollection 2024.
7
microRNAs Associated with Carotid Plaque Development and Vulnerability: The Clinician's Perspective.与颈动脉斑块形成和易损性相关的 microRNAs:临床医生的视角。
Int J Mol Sci. 2022 Dec 9;23(24):15645. doi: 10.3390/ijms232415645.
8
Ornithine Aspartate and Vitamin-E Combination Has Beneficial Effects on Cardiovascular Risk Factors in an Animal Model of Nonalcoholic Fatty Liver Disease in Rats.精氨酸天门冬氨酸与维生素 E 联合应用对非酒精性脂肪性肝病大鼠心血管危险因素的影响
Biomolecules. 2022 Nov 28;12(12):1773. doi: 10.3390/biom12121773.
9
The role of miRNAs in the diagnosis of stable atherosclerosis of different arterial territories: A critical review.微小RNA在不同动脉区域稳定动脉粥样硬化诊断中的作用:一项批判性综述。
Front Cardiovasc Med. 2022 Nov 25;9:1040971. doi: 10.3389/fcvm.2022.1040971. eCollection 2022.
10
Clinical Application of Serum microRNAs in Atherosclerotic Coronary Artery Disease.血清微小RNA在动脉粥样硬化性冠状动脉疾病中的临床应用
J Clin Med. 2022 Nov 20;11(22):6849. doi: 10.3390/jcm11226849.
多血管疾病:当前临床全景的再评估。
Circ Cardiovasc Interv. 2019 Dec;12(12):e007385. doi: 10.1161/CIRCINTERVENTIONS.119.007385. Epub 2019 Dec 13.
4
We are What We Eat: Impact of Food from Short Supply Chain on Metabolic Syndrome.我们吃什么,我们就是什么:短供应链食品对代谢综合征的影响。
J Clin Med. 2019 Nov 23;8(12):2061. doi: 10.3390/jcm8122061.
5
MicroRNAs as Potential Biomarkers in Atherosclerosis.微小 RNA 作为动脉粥样硬化的潜在生物标志物。
Int J Mol Sci. 2019 Nov 7;20(22):5547. doi: 10.3390/ijms20225547.
6
2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes.2019年欧洲心脏病学会慢性冠状动脉综合征诊断和管理指南
Eur Heart J. 2020 Jan 14;41(3):407-477. doi: 10.1093/eurheartj/ehz425.
7
Rivaroxaban Plus Aspirin Versus Aspirin in Relation to Vascular Risk in the COMPASS Trial.利伐沙班联合阿司匹林与阿司匹林在 COMPASS 试验中与血管风险的关系。
J Am Coll Cardiol. 2019 Jul 2;73(25):3271-3280. doi: 10.1016/j.jacc.2019.02.079.
8
MiR-423 is differentially expressed in patients with stable and unstable coronary artery disease: A pilot study.miR-423 在稳定性和不稳定性冠状动脉疾病患者中的表达差异:一项初步研究。
PLoS One. 2019 May 6;14(5):e0216363. doi: 10.1371/journal.pone.0216363. eCollection 2019.
9
Alirocumab in Patients With Polyvascular Disease and Recent Acute Coronary Syndrome: ODYSSEY OUTCOMES Trial.依洛尤单抗治疗多血管疾病及近期急性冠状动脉综合征患者:ODYSSEY OUTCOMES 试验。
J Am Coll Cardiol. 2019 Sep 3;74(9):1167-1176. doi: 10.1016/j.jacc.2019.03.013. Epub 2019 Mar 18.
10
2018 ESC/EACTS Guidelines on myocardial revascularization.2018年欧洲心脏病学会/欧洲心胸外科学会心肌血运重建指南。
Eur Heart J. 2019 Jan 7;40(2):87-165. doi: 10.1093/eurheartj/ehy394.